102 Chapter 4 Study population SOLUTION1 study Included women diagnosed with endometrial cancer: n=158 Included in the analysis: n=103 Excluded from current analysis, reason: n=40: Incomplete sample set n=1: Invalid test result clinician-taken cervical scrape n=5: Invalid test result urine sample n=4: No residual disease present during sample collection n=4: Minimal residual disease present during sample collection n=1: Second primary tumor diagnosis (lung cancer) Supplementary Figure 1: Flowchart illustrating excluded endometrial cancer patients (n=55) from the total study population (n=158) due to various reasons: incomplete sample-set (n=40), invalid test-result for DNA methylation analysis (n=6), no residual cancer during sample collection (n=4), minimal residual cancer (i.e. < 5 mm) during sample collection, and diagnosed with synchronous lung cancer (n=1).
RkJQdWJsaXNoZXIy MjY0ODMw